Armitage N - Search Results

1

Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence.

Hubner RA, Muir KR, Liu JF, Sellick GS, Logan RF, Grainge M, Armitage N, Chau I, Houlston RS. Hubner RA, et al. Among authors: armitage n. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1607-13. doi: 10.1158/1055-9965.EPI-06-0274. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985020 Free article.

2

Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR; ukCAP Trial Group. Logan RF, et al. Gastroenterology. 2008 Jan;134(1):29-38. doi: 10.1053/j.gastro.2007.10.014. Epub 2007 Oct 10. Gastroenterology. 2008. PMID: 18022173 Clinical Trial.

3

Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence.

Hubner RA, Muir KR, Liu JF, Logan RF, Grainge M, Armitage N, Shepherd V, Popat S, Houlston RS; United Kingdom Colorectal Adenoma Prevention Consortium. Hubner RA, et al. Among authors: armitage n. Clin Cancer Res. 2006 Nov 1;12(21):6585-9. doi: 10.1158/1078-0432.CCR-06-0903. Clin Cancer Res. 2006. PMID: 17085674 Clinical Trial.

4

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF. Lund JN, et al. Among authors: armitage nc. Gut. 2001 Jul;49(1):91-6. doi: 10.1136/gut.49.1.91. Gut. 2001. PMID: 11413116 Free PMC article. Clinical Trial.

5

A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer.

Armitage NC, Ballantyne KC, Sheffield JP, Clarke P, Evans DF, Hardcastle JD. Armitage NC, et al. Cancer. 1991 May 15;67(10):2599-604. doi: 10.1002/1097-0142(19910515)67:10<2599::aid-cncr2820671033>3.0.co;2-6. Cancer. 1991. PMID: 2015560

6

Intervention studies in adenoma patients.

Armitage NC. Armitage NC. World J Surg. 1991 Jan-Feb;15(1):29-34. doi: 10.1007/BF01658957. World J Surg. 1991. PMID: 1994602 Review.

7

DNA content of rectal mucosa and rectal mucosal proliferation in individuals at high risk of colorectal cancer.

Rooney PS, Clarke PA, Gifford KA, Hardcastle JD, Armitage NC. Rooney PS, et al. Among authors: armitage nc. Eur J Cancer Prev. 1994 Jan;3(1):57-61. doi: 10.1097/00008469-199401000-00008. Eur J Cancer Prev. 1994. PMID: 8130718

8

The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis.

Armitage NC, Ballantyne KC, Evans DF, Clarke P, Sheffield J, Hardcastle JD. Armitage NC, et al. Br J Cancer. 1990 Nov;62(5):852-6. doi: 10.1038/bjc.1990.393. Br J Cancer. 1990. PMID: 2245180 Free PMC article.

9

Primary aortoenteric fistula due to recurrent colorectal cancer. Report of a case.

Armitage NC, Ballantyne KC. Armitage NC, et al. Dis Colon Rectum. 1990 Feb;33(2):148-9. doi: 10.1007/BF02055546. Dis Colon Rectum. 1990. PMID: 2298102

10

Endoscopic screening of relatives of patients with colorectal cancer.

Hunt LM, Rooney PS, Hardcastle JD, Armitage NC. Hunt LM, et al. Among authors: armitage nc. Gut. 1998 Jan;42(1):71-5. doi: 10.1136/gut.42.1.71. Gut. 1998. PMID: 9505888 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters